Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The blood test market worldwide is today around $75-80 billion
CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit
The FDA nod marks a step forward in precision oncology, linking molecular diagnostics more tightly to therapy selection for advanced prostate cancer
The decision was driven by results from the Phase III CAPItello-281 trial,
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Subscribe To Our Newsletter & Stay Updated
